HomeTNXP • NASDAQ
Tonix Pharmaceuticals Holding Corp
add
$20.17
24.37%
After Hours:(0.84%)-0.17
$20.00
Closed: Mar 28, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.58M | -31.68% |
Operating expense | 23.88M | -16.92% |
Net income | -22.11M | 19.08% |
Net profit margin | -856.24 | -18.43% |
Earnings per share | -10.18 | -100.58% |
EBITDA | -21.51M | 16.73% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.78M | 295.93% |
Total assets | 162.89M | 5.46% |
Total liabilities | 23.33M | -52.32% |
Total equity | 139.56M | — |
Shares outstanding | 6.43M | — |
Price to book | 0.84 | — |
Return on assets | -43.59% | — |
Return on capital | -48.75% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.11M | 19.08% |
Cash from operations | -14.63M | 34.51% |
Cash from investing | -3.00K | 99.30% |
Cash from financing | 85.15M | 109.15% |
Net change in cash | 70.55M | 293.38% |
Free cash flow | -7.22M | 46.89% |
Previous close
$26.67
Day range
$19.42 - $25.77
Year range
$6.76 - $1,100.80
Market cap
129.79M USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
81
